Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA
Highly active antiretroviral therapy (HAART) has markedly prolonged the prognosis of HIV-1 patients. However, lifelong dependency on HAART is a continuing challenge, and an effective therapeutic is much desired. Recently, introduction of short hairpin RNA (shRNA) targeting the HIV-1 promoter was fou...
Main Authors: | Kei Higaki, Masako Hirao, Ai Kawana-Tachikawa, Shoichi Iriguchi, Ayako Kumagai, Norihiro Ueda, Wang Bo, Sanae Kamibayashi, Akira Watanabe, Hiromitsu Nakauchi, Kazuo Suzuki, Shin Kaneko |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118302038 |
Similar Items
-
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
by: Shoichi Iriguchi, et al.
Published: (2021-01-01) -
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease
by: Yoshihiro Iwamoto, et al.
Published: (2021-06-01) -
An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils
by: Huan-Ting Lin, et al.
Published: (2015-01-01) -
Silencing of transposable elements may not be a major driver of regulatory evolution in primate iPSCs
by: Michelle C Ward, et al.
Published: (2018-04-01) -
Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
by: Chul-Yong Park, et al.
Published: (2015-10-01)